Zenicor Medical Systems AB is a swedish medical technology company that was founded in 2003 and has since then grown to become one of the leading medtech companies in Europe in the fields of early diagnosis of arrhythmias and stroke prevention for health care.
Zenicor conducts its own product research and development. Research is conducted in conjunction with Karolinska Institutet and several other research centres in all markets. The aim is to continue to develop solutions that are in the forefront where research and international competitiveness are concerned.
Together with researchers from Karolinska Institutet, Zenicor has developed a unique system, Zenicor-ECG, for early detection and diagnosis of atrial fibrillation and other arrhythmias easily and cost-effectively. The effectiveness of the system has been proven in a large number of internationally acclaimed research studies that have been published in medical science journals. These studies have all shown that Zenicor-ECG, in combination with cost-effectiveness and ease of use, has a superior diagnostic accuracy compared to traditional methods. The use of Zenicor-ECG leads to a reduction in the number of stroke cases and lower healthcare costs.
Zenicor-ECG is now established in more than 350 clinics in the Nordics, Germany, Austria, Switzerland and Great Britain.